Get startedLog in
    Picture of Cannabis Bioscience International Holdings logo

    CBIH — Cannabis Bioscience International Holdings Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Cannabis Bioscience International Holdings, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

    2020
    May 31st
    2021
    May 31st
    2022
    May 31st
    2023
    May 31st
    2024
    May 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUSPROSPECTUS10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue0.290.7620.2150.3170.249
    Cost of Revenue
    Gross Profit0.290.7620.1680.2230.203
    Selling / General / Administrative Expenses
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses0.8310.9211.051.260.735
    Operating Profit-0.541-0.159-0.834-0.942-0.486
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-0.541-0.159-0.885-1.03-0.651
    Provision for Income Taxes
    Net Income After Taxes-0.541-0.159-0.885-1.03-0.651
    Net Income Before Extraordinary Items
    Net Income-0.541-0.159-0.885-1.03-0.651
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-0.541-0.159-0.885-1.03-0.651
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0-0-0-0-0